Inhibitor Therapeutics, Inc.
INTI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042418
No open-market purchases or sales by Inhibitor Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of INTI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Inhibitor Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Inhibitor Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Inhibitor Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 23, 2023 | Black Robe Capital LLC | 13DOld format | – | New | – | SEC |
| May 23, 2023 | TPB 2012 LLC | 13GOld format | – | New | – | SEC |
| May 18, 2023 | Ronald E Osman Irrevocable Trust III | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Inhibitor Therapeutics, Inc. shares.
No Form 144 notices for Inhibitor Therapeutics, Inc. are on file.